Suppr超能文献

[敲低基因表达对四氯化碳诱导的小鼠肝纤维化模型早期肝损伤的保护作用]

[Protective effect of knock-down the expression of gene on early liver injury in CCl-induced mouse model of liver fibrosis].

作者信息

Qin Q, Li R, Zhou Y, Zhang Y, Han M, Zhu L

机构信息

Peking University Ditan Teaching Hospital, Beijing 100015, China.

Beijing Key Laboratory of Emerging Infectious Diseases, Institute of Infectious Diseases, Beijing Ditan Hospital, Capital Medical University, Beijing 100015, China.

出版信息

Beijing Da Xue Xue Bao Yi Xue Ban. 2025 Aug 18;57(4):727-734. doi: 10.19723/j.issn.1671-167X.2025.04.016.

Abstract

OBJECTIVE

To explore the protective effect of knock-down the expression of B lymphocyte induced maturation protein 1 () gene on early liver injury in carbon tetrachloride (CCl)-induced mouse model of liver fibrosis.

METHODS

C57BL/6 mice were intraderitoneal injected with 5% CCl olive oil solution to create mouse model of hepatic fibrosis. The expression of gene in the mice was reduced by intraderitoneal injection of short hairpin RNA (shRNA) adeno-associated virus (AAV). The mice were randomly divided into 3 groups: blank test group (=10), CCl+AAV-shRNA-NC group (=10) and CCl+AAV-shRNA-Blimp1 group (=10). After 27 days of preparation of the CCl mouse model, animal materials were carried out. Western blot and real-time PCR were used to detect the levels of Blimp1, α-smooth muscle actin (α-SMA), collagen type Ⅰ alpha 1 (COL1A1), collagen type Ⅲ alpha 1 (COL3A1), and their mRNA expression levels of liver tissue in each group. The serum of each group was separated to measure aspartate transaminase (AST) and alanine transaminase (ALT) by automatic biochemical analyzer. The pathological changes of liver tissue and the degree of liver fibrosis in the mice were detected by pathological staining including hematoxylin-eosin staining, Masson, and Sirius red.

RESULTS

The expression levels of Blimp1 protein in the liver of CCl+AAV-shRNA-NC group (2.036±0.244, =3.690, =0.002) were significantly increased than that of the blank test group. In the CCl+AAV-shRNA-Blimp1 group, the expression of Blimp1 protein decreased to the basal level (0.783±0.249, =6.223, =0.003). Compared with the serum levels of ALT [(1 957.8±633.6) U/L] and AST [(1 808.8±260.1) U/L] in the CCl+AAV-shRNA-NC group, the serum levels of ALT [(894.0±360.1) U/L, =3.998, =0.003] and AST [(820.0±100.6) U/L, =6.141, =0.004] in the CCl+AAV-shRNA-Blimp1 group were significantly decreased. The pathological results of the CCl+AAV-shRNA-Blimp1 group showed that compared with the CCl+AAV-shRNA-NC group, the infiltration of inflammatory cells in the liver tissue was reduced and the degree of fibrosis was alleviated. The level of α-SMA (0.676±0.064, =7.930, =0.001), COL1A1 (1.426±0.143, =6.364, =0.003) and COL3A1 (1.124±0.198, =3.440, =0.026) of liver in the CCl+AAV-shRNA-Blimp1 group were significantly decreased than that of CCl+AAV-shRNA-NC group, and the mRNA expression levels were altered as well as their protein levels.

CONCLUSION

Blimp1 plays an important role in CCl-induced liver fibrosis in mice, and knock-down the expression of gene is beneficial to protect early liver injury in mice.

摘要

目的

探讨敲低B淋巴细胞诱导成熟蛋白1(Blimp1)基因表达对四氯化碳(CCl₄)诱导的小鼠肝纤维化早期肝损伤的保护作用。

方法

将C57BL/6小鼠腹腔注射5% CCl₄橄榄油溶液以建立肝纤维化小鼠模型。通过腹腔注射短发夹RNA(shRNA)腺相关病毒(AAV)降低小鼠体内Blimp1基因的表达。将小鼠随机分为3组:空白对照组(n = 10)、CCl₄ + AAV-shRNA-NC组(n = 10)和CCl₄ + AAV-shRNA-Blimp1组(n = 10)。在制备CCl₄小鼠模型27天后,进行取材。采用蛋白质免疫印迹法(Western blot)和实时荧光定量聚合酶链反应(real-time PCR)检测各组肝组织中Blimp1、α-平滑肌肌动蛋白(α-SMA)、Ⅰ型胶原蛋白α1(COL1A1)、Ⅲ型胶原蛋白α1(COL3A1)的水平及其mRNA表达水平。分离各组小鼠血清,用全自动生化分析仪检测天冬氨酸转氨酶(AST)和丙氨酸转氨酶(ALT)。通过苏木精-伊红染色、Masson染色和天狼星红染色等病理染色检测小鼠肝组织的病理变化及肝纤维化程度。

结果

CCl₄ + AAV-shRNA-NC组小鼠肝脏中Blimp1蛋白表达水平(2.036±0.244,t = 3.690,P = 0.002)明显高于空白对照组。在CCl₄ + AAV-shRNA-Blimp1组中,Blimp1蛋白表达降至基础水平(0.783±0.249,t = 6.223,P = 0.003)。与CCl₄ + AAV-shRNA-NC组血清ALT水平[(1 957.8±633.6)U/L]和AST水平[(1 808.8±260.1)U/L]相比,CCl₄ + AAV-shRNA-Blimp1组血清ALT水平[(894.0±360.1)U/L,t = 3.998,P = 0.003]和AST水平[(820.0±100.6)U/L,t = 6.141,P = 0.004]明显降低。CCl₄ + AAV-shRNA-Blimp1组病理结果显示,与CCl₄ + AAV-shRNA-NC组相比,肝组织中炎症细胞浸润减少,纤维化程度减轻。CCl₄ + AAV-shRNA-Blimp1组肝脏中α-SMA(0.676±0.064,t = 7.930,P = 0.001)、COL1A1(1.426±0.143,t = 6.364,P = 0.003)和COL3A1(1.124±0.198,t = 3.440,P = 0.026)水平明显低于CCl₄ + AAV-shRNA-NC组,其mRNA表达水平和蛋白水平均发生改变。

结论

Blimp1在CCl₄诱导的小鼠肝纤维化中起重要作用,敲低Blimp1基因表达有利于保护小鼠早期肝损伤。

相似文献

1
[Protective effect of knock-down the expression of gene on early liver injury in CCl-induced mouse model of liver fibrosis].
Beijing Da Xue Xue Bao Yi Xue Ban. 2025 Aug 18;57(4):727-734. doi: 10.19723/j.issn.1671-167X.2025.04.016.
3
Leonurine Attenuates CCl-Induced Hepatic Fibrosis in Mice via the Hippo-YAP Pathway.
Drug Des Devel Ther. 2025 Jul 30;19:6553-6571. doi: 10.2147/DDDT.S518793. eCollection 2025.
4
[LncRNA-UCA1-microRNA-143-Notch1 regulates autophagy in myocardial ischemia reperfusion injury induced by cardiopulmonary bypass].
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2025 Jun;37(6):576-582. doi: 10.3760/cma.j.cn121430-20240329-00298.
5
[Influence and mechanism of extracellular vesicles derived from human dermal papilla cells on skin fibrosis in mice].
Zhonghua Shao Shang Yu Chuang Mian Xiu Fu Za Zhi. 2025 Jun 20;41(6):559-568. doi: 10.3760/cma.j.cn501225-20240925-00348.
6
MBD2 deficiency attenuates CCl-induced hepatic fibrosis by inhibiting M2 macrophage polarization.
Int Immunopharmacol. 2025 Aug 6;164:115306. doi: 10.1016/j.intimp.2025.115306.
7
[Animal Modeling of Osteoporosis Combined With Liver Cirrhosis and Preliminary Investigation of the Comorbidity Mechanisms].
Sichuan Da Xue Xue Bao Yi Xue Ban. 2025 Mar 20;56(2):317-323. doi: 10.12182/20250360109.
8
[A stable mouse model of chronic liver fibrosis induced by vitamin A deficiency and intraperitoneal CCl injection].
Nan Fang Yi Ke Da Xue Xue Bao. 2025 Jul 20;45(7):1527-1534. doi: 10.12122/j.issn.1673-4254.2025.07.20.
10
[Effect of Wenpi Pills on lipid metabolism in mice with non-alcoholic fatty liver disease induced by various diets].
Zhongguo Zhong Yao Za Zhi. 2025 May;50(10):2730-2739. doi: 10.19540/j.cnki.cjcmm.20250120.401.

本文引用的文献

2
Hepatic fibrosis 2022: Unmet needs and a blueprint for the future.
Hepatology. 2022 Feb;75(2):473-488. doi: 10.1002/hep.32285. Epub 2022 Jan 11.
4
TGF-β in Hepatic Stellate Cell Activation and Liver Fibrogenesis-Updated 2019.
Cells. 2019 Nov 11;8(11):1419. doi: 10.3390/cells8111419.
5
Resolving the fibrotic niche of human liver cirrhosis at single-cell level.
Nature. 2019 Nov;575(7783):512-518. doi: 10.1038/s41586-019-1631-3. Epub 2019 Oct 9.
6
Chinese guidelines on management of hepatic encephalopathy in cirrhosis.
World J Gastroenterol. 2019 Sep 28;25(36):5403-5422. doi: 10.3748/wjg.v25.i36.5403.
7
ECM1 Prevents Activation of Transforming Growth Factor β, Hepatic Stellate Cells, and Fibrogenesis in Mice.
Gastroenterology. 2019 Nov;157(5):1352-1367.e13. doi: 10.1053/j.gastro.2019.07.036. Epub 2019 Jul 27.
9
CD5L is a pleiotropic player in liver fibrosis controlling damage, fibrosis and immune cell content.
EBioMedicine. 2019 May;43:513-524. doi: 10.1016/j.ebiom.2019.04.052. Epub 2019 May 8.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验